00002-E-1 – 1 December 2003 Anti-HIV drugs 2010-2011 Andrea De Luca, M.D. Institute of Clinical Infectious Diseases. Catholic University, Rome 2nd Division.
Listening to Consumers 101, How Marketers Can Leverage Consumer-Generated Media
Innovative Strategies for the Management of HIV Infection with Drs. Jean-Guy Baril and Réjean Thomas
1 Efficacy and safety of switching from boosted Lopinavir (LPV/r) to boosted Atazanavir (ATV/r) in patients with virologic suppression receiving a LPV/r.
Treatment of Hepatitis C in patients with thalassaemia. Where are we now? Telaprevir and boceprevir harbingers of important treatment advance Improved.
A qualitative study of functioning, disability, and rehabilitation of patients after hip fracture surgery Monica Milter Ehlers PhD student, MSc in Nursing.
The Intervention Program THE MISSING LINK IN BIOPHARMACEUTICAL SCIENCES TM.
Background
Effects of Patient Tracking Systems and Providers Incentives on Patient Appointment Keeping Rwanda Pilot Study Report Nyamusore Jose 1 *, Hinda Ruton 1,
HLA Testing: A Single Centre Experience Laura Waters, Andrea Gritz, Desmond Maitland, Brian Gazzard & Mark Nelson. Research Fellow PKR/SSR St. Stephen’s.
Innovative Strategies for the Management of HIV Infection
